Management Forum Logo

Presented by
Management Forum

CAPA (Corrective and Preventative Action) Training Course

This course will cover CAPA methodology and documentation, diagnosing process improvement, developing options for process improvement, and planning and implementation in process improvements and CAPA.

★★★★★ "The webinar was very enjoyable and I feel I have gained a lot of knowledge on this topic. As a begin... more (29)"

19 July 2024
+ 13 December 2024, 28 March 2025, 18 July 2025, 5 December 2025 »

from £549

Need help?  Enrol or reserve

Course overview

In today’s highly regulated pharma, biotech, device and animal health industries, it is essential to use the most efficient processes and ensure compliance with an active corrective and preventive action (CAPA) system.

CAPA procedures are a frequent focus of regulatory inspectors and evidence will be required at any future inspections that CAPA actions have been implemented.

This course will provide you with an understanding of how to improve your processes and implement and document an effective CAPA quality system. The programme will include discussion of CAPA examples and case studies to enhance course learning.

This course is part of our Regulatory Affairs Training course collection, which features updates on the latest regulations to registration procedures and strategies.

Benefits of attending

  • Understand CAPA methodology and documentation
  • Learn tools and techniques to help make your existing processes more efficient and compliant
  • Discover how you can address inspection findings using CAPA and process improvement
  • Share best practice for CAPA

Who should attend?

This course has been specifically designed for those working in the pharma, biotech, device or animal health industries who are involved in process improvement and CAPA requirements.

Enrol or reserve

This course will cover:

Why is CAPA important?

Best practice for CAPA

CAPA methodology and documentation

  • Identification
  • Evaluation
  • Investigation
  • Analysis
  • Action plan
  • Implementation – execute the action plan, eg stakeholder analysis, the transition curve
  • Follow-up – verify and assess the effectiveness of the CAPA
  • Finding(s)

Diagnosing process improvement

  • Using problem diagnosis (eg ‘root cause’ analysis) to understand why processes are unwieldy and help facilitate how to resolve inspection and audit findings

Developing options for process improvement and CAPA

  • Being more creative in problem solving of process simplification issues
  • Flowcharts
  • Evaluation of the attractiveness/likely difficulty of changes
  • Continuous improvement – an invaluable approach for improving the implementation of regulatory change

Planning and implementation in process improvements and CAPA

  • Project managing process improvements and CAPA
  • Managing the change and people issues
  • Managing the stakeholders involved (stakeholder analysis)

Enrol or reserve

Laura Brown
LB Training and Development Ltd

Dr Laura Brown is an independent pharmaceutical QA consultant and is a recognised expert in QA including auditing SOPs for regulatory compliance. She has more than 25 years’ international experience in the pharmaceutical industry in a number of senior roles and has worked for companies including GSK, Hoechst Marion Roussel, Farmitalia and Phoenix International. She has worked in several quality assurance roles which have included writing, reviewing and auditing SOPs and CAPA implementation and has helped companies prepare SOPs and review CAPA systems to meet regulatory requirements.

More details

NEW higher discounts for multiple bookings - bring your colleagues to make your training budget go further:

  • 30% off the 2nd delegate*
  • 40% off the 3rd delegate*
  • 50% off the 4th delegate*

Please contact us for pricing if you are interested in booking 5 or more delegates

19 July 2024

09:30-17:00 UK (London) (UTC+01)
10:30-18:00 Paris (UTC+02)
04:30-12:00 New York (UTC-04)
Course code 13815

  • GBP 649
  • EUR 929
  • USD 1,049

View basket 

Not ready to book yet?

for 7 days, no obligation

13 December 2024

Live online

09:30-17:00 UK (London) (UTC+00)
10:30-18:00 Paris (UTC+01)
04:30-12:00 New York (UTC-05)
Course code 14089

  • GBP 549 649
  • EUR 789 929
  • USD 893 1,049

Until 08 Nov

View basket 

Not ready to book yet?

for 7 days, no obligation

28 March 2025

Live online

09:30-17:00 UK (London) (UTC+00)
10:30-18:00 Paris (UTC+01)
05:30-13:00 New York (UTC-04)
Course code 14628

  • GBP 549 649
  • EUR 789 929
  • USD 893 1,049

Until 21 Feb

View basket 

Not ready to book yet?

for 7 days, no obligation

18 July 2025

Live online

09:30-17:00 UK (London) (UTC+01)
10:30-18:00 Paris (UTC+02)
04:30-12:00 New York (UTC-04)
Course code 14859

  • GBP 549 649
  • EUR 789 929
  • USD 893 1,049

Until 13 Jun

View basket 

Not ready to book yet?

for 7 days, no obligation

5 December 2025

Live online

09:30-17:00 UK (London) (UTC+00)
10:30-18:00 Paris (UTC+01)
04:30-12:00 New York (UTC-05)
Course code 15147

  • GBP 549 649
  • EUR 789 929
  • USD 893 1,049

Until 31 Oct

View basket 

Not ready to book yet?

for 7 days, no obligation

* Early booking discounts may not be combined with other discounts or offers. As such, the discounts for 2nd/3rd/4th delegates are based on the full price; and apply only when booking multiple delegates on the same date.

Reviews of IPI's CAPA (Corrective and Preventative Action) training course

The whole webinar was very interesting

Jul 18 2023

Olga Kirchner
Quality Assistant, FMP Ltd

Jul 18 2023

Great course, understandable and interactive.

Caroline Pascoe
Quality Assistant, Flexible Medical Packaging Ltd

Sep 27 2022

The webinar was very enjoyable and I feel I have gained a lot of knowledge on this topic. As a beginner to the process it was very informative but it may not be as useful for more experienced people.

Philippa Carslake
Technical Officer, Alliance Healthcare

Jun 28 2022

My overall opinion of this webinar is that, the content was informative and included several important aspects of the relative subject. It was well presented and as clear as possible by the speaker. When questions were asked, the speaker cam back with the respective adequate answers.

Davinia Cardona
Document Controller, Orphalan Ltd.

Jun 28 2022

Very informative and clear

Christine Meilak Mercieca
Senior Quality Associate , Orphalan Ltd

Jun 29 2021

Great session, thank you

Kasia Stathers
Vigilance Officer , Reckitt Benckiser Group

Dec 3 2021

It was a pleasure to meet Laura Brown. She was very knowledgeable about CAPA and explained in a simple way all the steps to understand the CAPA process.

Oscar Ortego
Export Veterinary Auditor , Food Standards Agency

Jun 29 2021

Really useful refresher on CAPA and the processes used. It has helped me prioritise and categorise CAPA types, and I found particularly useful the section on risk scoring and utilising the risk register for those classified as minor.

Claire Crewe
QA Maanger, JensonR+

Dec 4 2020

I thought that giving the difficult situation with remote training it was well run.

Fiona Kermode
Panacea Pharma Projects

Dec 3 2019

A very talented speaker.

Mario Mohos
Quality Supervisor, Mylan Hungary Kft

Dec 3 2019


Hannah Allende
Assistant Clinical Trials Manager, University Hospitals Plymouth NHS Trust

Jun 29 2018

Excellent content, good speaker. Interacted with everyone.

Faiz Aziz
Technologist , Colorcon

Jun 29 2018

Excellent speaker, good presentation and content.

Faiz Aziz
Technologist , Colorcon

Dec 4 2018

Very clear, friendly and knowledgable.

Claire McGuinness
Medical Research Chemist, Mexichem

Dec 4 2018

Very good.

Heidrun Mylius
Senior Medical Writer & Process Improvement Manager, Medac GmbH

Dec 4 2018

The course was well planned and executed. The balance of the course overhead slides and practical exercises were well balanced. This course is very good for anyone wanting to understand CAPA planning and Root Cause analysis. I would highly recommend this course to any Quality/ Production persons in the Pharma industry. Well done Management Forum!

Sameer Hashmi
Quality Associate, Animalcare

Dec 7 2017

It was well packaged, concise and to the point.

Bolutife Adeyemi
Senior PV Associate, GW Pharmaceuticals plc

Dec 7 2017

Pleasant, friendly, engaging and very knowledgable

Diana Kalmoni-Hassay
Reports, Submissions and Compliance Associate, GW Pharmaceuticals plc

Dec 7 2017

Informative and engaging. Thoroughly enjoyed it

Malgorzata Wilinska
Research Associate, University of Cambridge

Dec 7 2017

Very good, interesting and enjoyable

Chris Martin
Quality Engineer, Remote Diagnostic Technologies Ltd

Jun 30 2017


Olga Vorobyeva
QMS Specialist , Arriello

Jun 30 2017

Very good overview

Alexandra Beer
Senior Quality Manager, Animax Ltd

Dec 6 2016

Useful course which I have definitely benefited from attending

Ken Barratt
Production & Quality Manager, The National Artificial Eye Service

Jul 1 2016

Was about right, good fun approach and professional delivery

Sandie Holmes
QA, Regulis Consulting Ltd

Jul 1 2016

Well thought through

Liz King
Director of Research and Development, Oxford Pharmascience

Jul 1 2016

Very well put together and good use of group work. The course was very informative and used good examples for analysis. Good use of all participants present.

Jas Sangha
Mundipharma Research Ltd

Dec 6 2016

Enjoyable course, with a very good presenter.

Sophie Thompson
Quality Engineer, Wesley Coe (Cambridge) Limited

Dec 6 2016

I found it useful and was happy to attend this course again

Esther Janssen
Compliance Manager, Ferring Pharmaceuticals A/S

Jul 1 2016

Accurate and exhaustive content, very interesting presentation, alive presentation without borrowing time

Karine Faller
Team leader QARA, Bernafon

United Kingdom

  • Torbay Pharmaceuticals
  • A.Menarini Farmaceutica Int SRL
  • Abbott Healthcare Products Ltd
  • Abbott Laboratories Ltd
  • ADAMAS Consulting Ltd
  • Allergan Limited
  • Alliance Healthcare
  • Animalcare
  • Animax Ltd
  • Arnold & Porter (UK) LLP
  • Associates of Cape Cod Inc
  • AstraZeneca
  • AstraZeneca R&D Charnwood
  • AstraZeneca UK Ltd
  • Bayer Healthcare
  • Bayer plc
  • Besins Healthcare Pharma Services
  • Bespak Europe Ltd
  • Biogen
  • BOC Micro applications centre
  • Bray Group Ltd
  • Carclo Technical Plastics
  • Celgene Europe Ltd
  • Chesapeake Pharmaceutical & Healthcare Packaging
  • Chiesi
  • Colorcon
  • Colorcon Limited
  • DA Consulting Ltd
  • Daiichi Sankyo UK Ltd
  • Depuy CMW
  • DHL Hospital Logistics Centre
  • DHLSupply Chain
  • Eisai Europe Limited
  • Flexible Medical Packaging Ltd
  • FMP Ltd
  • Food Standards Agency
  • Goldenzone Ltd
  • GSK
  • GW Pharmaceuticals
  • GW Pharmaceuticals Limited
  • GW Pharmaceuticals plc
  • Imanova Limited
  • Interport Ltd
  • Ipsen
  • JensonR+
  • KPMG
  • Kyowa Kirin International plc
  • Magstim Company Ltd
  • Mediplus
  • Mercury Pharma Management Services Ltd
  • Mexichem
  • Morningside Healthcare Limited
  • MSD Ltd
  • Mundipharma Research Ltd
  • Necessity Supplies Ltd
  • Novo Nordisk Ltd
  • Nutricia Ltd
  • Owen Mumford Ltd
  • Oxford Pharmascience
  • Panacea Pharma Projects
  • Pfizer Limited
  • Pharmaspec Specials
  • Philips Respironics
  • Procter & Gamble
  • ProductLife Limited
  • ProductLife Ltd
  • Public Health England
  • Rayner Intraocular Lenses Ltd
  • Reckitt Benckiser Group
  • Regulis Consulting Limited
  • Regulis Consulting Ltd
  • Remote Diagnostic Technologies Ltd
  • Roche Products Ltd
  • Sanofi Pasteur MSD Ltd
  • Sekisui Diagnostics (UK) Ltd
  • Sharp Life Science (EU) Ltd
  • SincasPharma
  • Takeda Development Centre Europe Ltd
  • Teva UK Ltd
  • The Magstim Company Ltd
  • The National Artificial Eye Service
  • The Straumann Group
  • Torbay Pharmaceuticals
  • University Hospitals Plymouth NHS Trust
  • University of Cambridge
  • Vifor Pharma UK Limited
  • Wesley Coe (Cambridge) Limited


  • Actelion A Janssen Pharmaceutical Company of Johns
  • Actelion Pharmaceutical Ltd
  • Bayer Consumer Care AG
  • Bernafon
  • Celgene International
  • Celgene International Sarl
  • F. Hoffmann-La Roche Ltd
  • GSK Consumer Healthcare S.A
  • Idorsia Pharmaceuticals Ltd
  • Merck Serono SA
  • Novartis Consumer Health SA
  • Skan AG


  • Chiesi SA NV
  • Federal Agency for Medicines and Health Products
  • Genzyme Flanders NV/SA
  • IBA
  • International Bar News
  • Ion Beam Applications SA
  • Keyrus Biopharma
  • s.a. Lundbeck nv
  • SGS Belgium NV Life Science Services
  • UCB Pharma SA
  • Words & Science


  • Actavis A/S
  • Boehringer-Ingelheim Danmark A/S
  • Copenhagen HIV Programme
  • Ferring Pharmaceuticals A/S
  • H. Lundbeck A/S
  • LEO Pharma A/S
  • Neurodan A/S
  • Novo Nordisk A/S. Company Member no. 3431
  • Pharmacosmos A/S
  • SSI Diagnostica
  • Takeda Pharma A/S


  • AWD Pharma GmbH & Co KG
  • Bayer Pharma AG
  • Berlin-Chemie AG
  • Medac GmbH
  • Merck KGaA
  • MorphoSys AG
  • MSD AH Innovation GmbH
  • Mundipharma Research GmbH & Co Kg


  • Astellas BV
  • Aurobindo Pharma B.V.
  • Bayer Medical Care BV
  • Boehringer Ingelheim BV
  • Genzyme Europe BV
  • Intervet International BV MSD Animal Health
  • Janssen Biologics BV
  • Zoetis


  • Menarini Ricerche S.p.A.
  • Actelion Pharmaceuticals Italia Srl
  • Alfa Wassermann S.p.A.
  • Alfrapharma Srl
  • Chiesi Farmaceutici SPA
  • Novartis Vaccines & Diagnostics SRL
  • Zambon S.p.A.


  • ALEXION Europe SAS
  • Institut de Rercherches Internationales Servier
  • Pierre Fabre Medicament
  • Sanofi Pasteur Siege mondial
  • Sanofi-Aventis R&D

Slovak Republic

  • Ewopharma International s.r.o
  • EWOPHARMA International s.r.o.
  • Ewopharma International, s.r.o.


  • Almus Farmaceutica
  • Industrias Farmaceuticas Almiral S.A.
  • Laboratorios CINFA


  • EGIS Pharmaceuticals PLC
  • Mylan Hungary Kft


  • Roche (Israel) Pharmaceuticals
  • TEVA


  • Orphalan Ltd
  • Orphalan Ltd.


  • Institute for Energy Technology
  • VESO Vikan


  • Ewopharma AG
  • SC Pharma Serv International Srl


  • Medis d.o.o
  • Salus, Veletrgovina, d.o.o


  • Boehringer Ingelheim
  • Boehringer Ingelheim Ilaç Tic. A.S.


  • PrimeVigilance Zagreb d.o.o.

Czech Republic

  • Arriello


  • Cipla Ltd


  • JSC Olainfarm


  • Generis Farmacêutica S.A.


  • CTC Clinical Trial Consultants AB


  • SmartlineGroup

United States of America

  • Celgene

Enrol or reserve

Run CAPA (Corrective and Preventative Action) Live online for your team

1 day

Typical duration

Pricing from:

  • GBP 450
  • Per attendee, based on 10 attendees
  • Course tailored to your requirements
  • At your choice of location, or online


We can customise this course to your requirements and deliver it on an in-house basis for any number of your staff or colleagues.

Contact our in-house training experts Aleksandra Beer and Yesim Nurko to discuss your requirements:

Multiple colleagues? See above for details of our discounts for 2, 3, or 4 delegates. For more, talk to one of our training experts to discuss how to:

Run this course conveniently and cost-effectively in-house for your staff and colleagues

Aleksandra Beer

Aleksandra BEER
Training expert

Yesim Nurko

Training expert

+44 (0)20 7749 4749